Tenaya Therapeutics awarded Chief Medical Officer Tingley Whittemore 49,000 shares at $0 per share on September 10, 2026. The award left Whittemore with 263,073 shares, while a separate grant covered 293,000 derivative securities. Investors have specific visibility into the executive’s resulting holdings and the award’s zero-cost terms.
Key Highlights
- Tingley Whittemore received 293,000 derivative securities in a separate award on September 10, 2026.
- The share award represented about 18.6% of Whittemore’s resulting shareholding.
- The transaction carried code A, which denotes an award or grant.
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) awarded Chief Medical Officer Tingley Whittemore 49,000 shares at $0 per share on September 10, 2026. Whittemore’s resulting holding stood at 263,073 shares. The same date also brought an award of 293,000 derivative securities, leaving Whittemore with 293,000 derivative securities after the transaction. The filing reported the awards under transaction code A.
Share Award Details
The 49,000-share grant represented about 18.6% of Whittemore’s resulting shares holding. The derivative securities award represented about 100.0% of the resulting derivative securities holding. The filing reported the awards under transaction code A. The share award had a stated price of $0 per share, while the derivative securities award was recorded separately from the 49,000 shares. Whittemore serves as Tenaya Therapeutics’ Chief Medical Officer. The resulting holdings reported after the awards were 263,073 shares and 293,000 derivative securities. Transaction code A denotes an award, grant, or other Acquisition from the company.
FAQs
Q: How many Tenaya Therapeutics shares did Tingley Whittemore receive?
A: Tenaya Therapeutics awarded Chief Medical Officer Tingley Whittemore 49,000 shares at $0 per share. The award occurred on September 10, 2026.
Q: What was the impact of the TNYA share award on Whittemore’s holdings?
A: After the 49,000-share award, Whittemore’s resulting Tenaya Therapeutics shareholding was 263,073 shares. The filing stated that the award represented about 18.6% of that resulting shareholding.
Q: Did Tingley Whittemore receive derivative securities?
A: Yes. The filing reported that Whittemore was awarded 293,000 derivative securities on September 10, 2026. Following the award, Whittemore’s resulting derivative securities holding was 293,000.
Q: What transaction code was reported for this TNYA transaction?
A: The filing reported transaction code A for the 49,000 shares and the 293,000 derivative securities awarded on September 10, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.